Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioCryst: The Next Orphan Drug $1B+ Company
BioCryst: The Next Orphan Drug $1B+ Company
BioCryst: The Next Orphan Drug $1B+ Company
Submitted by
admin
on August 3, 2013 - 10:27am
Source:
Seeking Alpha
News Tags:
Biocryst
BCX4161
angioedema
Headline:
BioCryst: The Next Orphan Drug $1B+ Company
Do Not Allow Advertisers to Use My Personal information
